Peter F. Carpenter

Last updated
Peter F. Carpenter
Born1940 (age 83–84)
San Francisco, CA
NationalityAmerican
Education Harvard University (1962)
University of Chicago (1965)
Occupation(s)Business executive
Philanthropist
PartnerJane E. Shaw Carpenter
Children1

Peter F. Carpenter (born 1940) is an American philanthropist and former business executive. Born in San Francisco, Carpenter lived in Florida during his high school years, joining a volunteer fire department. While attending Harvard University for a degree in chemistry, he spent the summers as a smokejumper for the United States Forest Service. After graduating from Harvard in 1962, he became an officer in the United States Air Force. In the 1960s and 70s, he worked for various employers, including Lockheed, Stanford University, and the US Price Commission. He started working for the ALZA Corporation, a pharmaceutical company, in 1976. In 1990, he left his executive vice president position to work in nonprofit leadership. From 2001 to 2018, he served several terms on the board of the Menlo Park Fire District.

Contents

Carpenter has been on the board of several nonprofits, including the American Foundation for AIDS Research (1985–1991), Annual Reviews (1994–present), and Village Enterprise Fund (1997–2009).

Early life and education

Peter F. Carpenter was born in San Francisco, California in 1940. [1] [2] Carpenter's father was in the Navy during World War II. [3] He was part of the Boy Scouts of America, becoming an Eagle Scout in 1955. [4] During his high school years, Carpenter lived in rural north Florida, where he was a volunteer firefighter; he helped with both structural and wildland fires. [3] Carpenter graduated with a Bachelor of Arts in chemistry from Harvard University in 1962. [5] His family had the expectation that he would enlist in the armed forces, so he participated in the ROTC at Harvard. [3] [6] He then attended the University of Chicago, graduating with an MBA in 1965. [5]

Career

From 1959–1961, Carpenter was a smokejumper for the United States Forest Service in Redding, California during his summer breaks from Harvard. After his graduation in 1962, he was commissioned as an officer in the United States Air Force, where he had an assignment as a test parachutist because of his smokejumping experience. [3] From 1966–1968, he was the Vietnam program manager for the Advanced Research Projects Agency and served as the Air Force Aide to the White House. In 1969, he was a consultant for Lockheed, where he developed marketing strategies for its Airborne System Division. From 1968–1970, he was assistant director of the Stanford University Center for Materials Research. [5]

He worked as deputy executive director at the US Price Commission from 1971 to 1973, [4] where he investigated illegal price inflation tactics by lumber companies. [7] [8] [9]

In 1976, he began working for the ALZA Corporation, a pharmaceutical company. [4] At ALZA, he oversaw the "highly unusual" and "revolutionary" decision in 1987 to require women to sign an informed consent form to receive their IUD "Progestasert". [10] [11] In 1987, The Washington Post noted that ALZA was "the only pharmaceutical manufacturer to try to make informed consent a condition for use of a marketed prescription product". [12] For several years starting in January 1986, ALZA manufactured the only IUDs available for sale in the US. [11] [12] In 1990, he left his position as executive vice president of ALZA to pursue nonprofit work. [13] In 1993, he testified before the United States House Committee on Small Business, in which he stated that "uncontrolled population growth is the most serious threat there is to the environment, to international stability, and to economic well-being". He noted that reproductive research in the US was underfunded, and provided guidance on what the role of the federal government should be regarding reproductive research. [14] He was also executive director of Stanford University Medical Center and visiting scholar at the Center for Biomedical Ethics at Stanford. [15]

In 2001, he was selected to fill a vacancy on the district board of the Menlo Park Fire District. [16] He was elected to the board three times and appointed once more, becoming the longest-serving board member in the history of the fire district. He stepped down from the board in 2018 after not running for reelection. [17]

Philanthropy

Carpenter has had leadership positions with a variety of non-profit, cultural, and research organizations. In 1991, he founded the Mission and Values Institute. [4] He has been on the board of directors for the publishing company Annual Reviews since 1994. [4] [18] From 1985–1991, he was director of the American Foundation for AIDS Research. [4] From 1997 to 2009, he was on the board of directors of the Village Enterprise Fund. [4] In 2006, he became director of the humanitarian organization InSTEDD. [19] [4] He and his wife Jane Shaw have supported several education initiatives in California, Tanzania, and Bhutan. [20]

Personal life

Carpenter is married to Jane Shaw Carpenter, also a former business executive at ALZA [21] and co-inventor of the scopolamine transdermal patch to treat motion sickness. [22] They have one son, Jonathan Carpenter. [23] Around 2001, he was diagnosed with chronic lymphocytic leukemia (CLL), [24] and he has stated that he was first veteran to be granted benefits by United States Department of Veterans Affairs acknowledging his cancer was a result of Agent Orange exposure during his time in Vietnam. [25]

Related Research Articles

<span class="mw-page-title-main">Scopolamine</span> Tropane alkaloid & anticholinergic drug

Scopolamine, also known as hyoscine, or Devil's Breath, is a natural or synthetically produced tropane alkaloid and anticholinergic drug that is used as a medication to treat motion sickness and postoperative nausea and vomiting. It is also sometimes used before surgery to decrease saliva. When used by injection, effects begin after about 20 minutes and last for up to 8 hours. It may also be used orally and as a transdermal patch since it has been long known to have transdermal bioavailability.

<span class="mw-page-title-main">Alza</span> Former American pharmaceutical and medical systems company

Alza Corporation was an American pharmaceutical and medical systems company.

<span class="mw-page-title-main">Transdermal patch</span> Adhesive patch used to deliver medication through the skin

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method. The first commercially available prescription patch was approved by the U.S. Food and Drug Administration in December 1979. These patches administered scopolamine for motion sickness.

<span class="mw-page-title-main">William R. Brody</span> American radiologist and academic administrator

William Ralph Brody is an American radiologist and academic administrator. He was the President of The Johns Hopkins University, a position which he held from 1996 to 2009 before becoming the President of the Salk Institute from 2009 to 2015.

<span class="mw-page-title-main">Yusuf Hamied</span> Indian scientist and businessman

Yusuf Khwaja Hamied is an Indian scientist, billionaire businessman and the chairman of Cipla, a generic pharmaceuticals company founded by his father Khwaja Abdul Hamied in 1935. He is also an elected fellow of the Indian National Science Academy.

Jeffrey B. Kindler is an American healthcare executive and private investor. He served as chairman and CEO of the pharmaceutical company Pfizer from 2006 to 2010. Kindler has later served as CEO of Centrexion Inc., and chairman of the GLG Institute.

Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.

<span class="mw-page-title-main">Peter Löscher</span> Austrian manager (born 1957)

Peter Löscher is an Austrian manager who was the CEO of Siemens from 2007 until 2013. As of 2017, Löscher remains as the only CEO to be hired from outside the conglomerate in the 170-year history of Siemens. Before joining Siemens, he worked as president for Global Human Health at global pharmaceutical company Merck & Co.

William C. Weldon is a former chairman of Johnson & Johnson, He was the eighth chairman in Johnson & Johnson's history of more than one hundred years.

<span class="mw-page-title-main">PPD, Inc.</span> Global contract research organization

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.

<span class="mw-page-title-main">Martin Gerstel</span> Israeli businessman (born 1941)

Martin Gerstel is an Israeli businessman. He was the CEO and co-chairman of Alza Corp. Martin Gerstel founded ALZA Corp. and Itamar Medical Ltd. M

<span class="mw-page-title-main">Mariano-Florentino Cuéllar</span> American judge (born 1972)

Mariano-Florentino "Tino" Cuéllar is an American scholar, jurist, and nonprofit executive currently serving as the 10th president of the Carnegie Endowment for International Peace. He was previously a Justice of the Supreme Court of California, the Stanley Morrison Professor of Law at Stanford University and director of Stanford's Freeman Spogli Institute for International Studies, and an executive branch official in the Clinton and Obama administrations. His publications address problems in American public law, international affairs and international law, artificial intelligence, public health and safety law, and institutions and organizations. He serves on the State Department's Foreign Affairs Policy Board. A member of the American Academy of Arts and Sciences and the National Academy of Sciences Committee on the Social and Ethical Implications of Computing Research, he serves as chair of the board of the William and Flora Hewlett Foundation. He was born in Northern Mexico.

<span class="mw-page-title-main">J. Michael Pearson</span>

J. Michael Pearson is a Canadian American pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.

Chris Viehbacher is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.

<i>Planes: Fire & Rescue</i> 2014 American Disneytoon film

Planes: Fire & Rescue is a 2014 American animated comedy-adventure film produced by Disneytoon Studios and released by Walt Disney Pictures. Directed by Bobs Gannaway, written by Gannaway and Jeffrey M. Howard, and produced by Ferrell Barron, it is a sequel to Planes (2013), itself a spin-off of Pixar's Cars franchise. Dane Cook, Stacy Keach, Brad Garrett, Teri Hatcher, Danny Mann, and Cedric the Entertainer reprised their roles with new additions to the cast including Hal Holbrook, Julie Bowen, Ed Harris, Regina King, Wes Studi, Patrick Warburton, and Dale Dye. In the film, Dusty Crophopper (Cook) is assigned to become a wildland firefighting plane in Piston Peak National Park after he learns that his engine's gearbox is damaged.

<span class="mw-page-title-main">Alan Garber</span> American physician (born 1955)

Alan Michael Garber is an American physician, health economist, and academic administrator. He is Harvard University's 31st president.

<span class="mw-page-title-main">F. Eugene Yates</span> American physiologist (1927–2015)

Francis Eugene Yates was an American physiologist and a professor of medicine and medical engineering at University of California Los Angeles.

<span class="mw-page-title-main">Raphael Bostic</span> American economist, academic, and public servant

Raphael W. Bostic is an American economist, academic, and public servant who has served as the 15th president and CEO of the Federal Reserve Bank of Atlanta since 2017. During his academic career, Bostic served as chair of the Department of Governance, Management, and the Policy Process at the Price School of Public Policy at the University of Southern California.

Ramon Martin Chavez is an American investment banker and entrepreneur. He is vice chairman and partner of Sixth Street Partners. Previously, he served in a variety of senior roles at Goldman Sachs, including chief information officer (2014–2017), chief financial officer, and global co-head of the firm's Securities Division. Marty was also a partner and member of Goldman's management committee. He was the chief technology officer and co-founder of Quorum Software Systems and CEO and co-founder of Kiodex. He is chairman of the board of computational pharmaceutical company Recursion, Board Observer of biotech company Earli and longevity biopharma company Cambrian Biopharma, and board member of Alphabet Inc.

BeiGene, Ltd. is a China-based drug developer. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has offices in North America, Europe, South America, Asia and Australia. BeiGene has a large presence in the Chinese market. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor.

References

  1. ↑ "Political Philosophy for Peter F. Carpenter". Smart Voter. 5 November 2013. Retrieved 26 August 2020.
  2. ↑ Thorwaldson, Jay (20 December 2011). "On Deadline blog: Peter Carpenter's mission: warn of employee-benefit 'time bomb'". Palo Alto Online. Retrieved 26 August 2020.
  3. 1 2 3 4 "Peter Carpenter". The Smokey Generation. August 2015. Retrieved 26 August 2020.
  4. 1 2 3 4 5 6 7 8 "Full Biography for Peter F. Carpenter". Smart Voter. 5 November 2013. Retrieved 26 August 2020.
  5. 1 2 3 Adequacy of the administration's anti-inflation program. U.S. Government Printing Office. 1979. p. 542.
  6. ↑ "ROTC Will Drill At Joint Review". The Harvard Crimson. 18 May 1962. Retrieved 3 September 2020.
  7. ↑ Cowan, Edward (21 November 1972). "Price Panel Opens Study Of Rising Lumber Costs". The New York Times. Retrieved 26 August 2020.
  8. ↑ "Lumber Controls Criticized at Hearing". The New York Times. 20 October 1972. Retrieved 26 August 2020.
  9. ↑ Tomasson, Robert E. (14 January 1973). "Lumber Costs Smashing Control Barriers". The New York Times. Retrieved 26 August 2020.
  10. ↑ "Where IUDs Stand". The Washington Post. 9 August 1988. Retrieved 3 September 2020.
  11. 1 2 Colburn, Don (19 November 1987). "Consent forms to accompany IUDs". The Journal News. White Plains, New York. Retrieved 26 August 2020.
  12. 1 2 "IUD MAKER GAMBLES ON THE INFORMED CONSUMER". The Washington Post. 15 March 1987. Retrieved 3 September 2020.
  13. ↑ Spragins, Ellyn (3 February 2002). "LOVE & MONEY; His Thoughts About Her Earning Their Keep". The New York Times. Retrieved 25 August 2020.
  14. ↑ Norplant and Contraceptive Pricing: Conflict of Interest, Protection of Public Ownership in Drug Development Deals Between Tax-exempt, Federally Supported Labs and the Pharmaceutical Industry. U.S. Government Printing Office. 1994. pp. 211–217. ISBN   9780160439124.
  15. ↑ Institute of Medicine; Committee to Study Decision Making; Division of Health Sciences Policy (1991). Hanna, Kathi E. (ed.). Biomedical Politics (Report). p. 332. doi:10.17226/1793. ISBN   978-0-309-04486-8. PMID   25121217.{{cite report}}: |author3= has generic name (help)
  16. ↑ Softky, Marion (28 March 2001). "Peter Carpenter of Atherton joins fire board". The Almanac. Retrieved 1 September 2020.
  17. ↑ Wood, Sue (20 December 2018). "Fire District's Longest-Serving Board Member Calls It Quits". Patch. Retrieved 1 September 2020.
  18. ↑ "Annual Reviews Board of Directors". Annual Reviews.
  19. ↑ "InSTEDD Edited: Humanitarian Technology Review". iRevolutions. 6 April 2020. Retrieved 26 August 2020.
  20. ↑ "DONOR PROFILE – PETER AND JANE SHAW CARPENTER". Philanthropic Ventures Foundation. Retrieved 26 August 2020.
  21. ↑ Enkelis, Liane; Olsen, Karen; Lewenstein, Marion (1995). On Our Own Terms: Portraits of Women Business Leaders. Berrett-Koehler. pp. 72–81. ISBN   1881052699.
  22. ↑ "Method and therapeutic system for administering scopolamine transdermally" . Retrieved 1 September 2020.
  23. ↑ "Caroline Nolan and Jonathan Carpenter". The New York Times. 4 September 2005. Retrieved 25 August 2020.
  24. ↑ Carpenter, Peter (19 February 2004). "The Journey of a Newly Diagnosed CLL Patient". CLL Topics. Retrieved 3 September 2004.
  25. ↑ Agent Orange (video). C-SPAN. 6 January 2010. Event occurs at 1:05:27-1:06:30. Retrieved 1 September 2020.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.